OrthoPediatrics (KIDS) Competitors $22.38 -0.21 (-0.93%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KIDS vs. TNDM, TMDX, SLNO, RXST, INMD, MDXG, ESTA, BLFS, PLSE, and AORTShould you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), and Artivion (AORT). These companies are all part of the "medical equipment" industry. OrthoPediatrics vs. Tandem Diabetes Care TransMedics Group Soleno Therapeutics RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Tandem Diabetes Care (NASDAQ:TNDM) and OrthoPediatrics (NASDAQ:KIDS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, community ranking, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability. Do insiders & institutionals have more ownership in TNDM or KIDS? 69.1% of OrthoPediatrics shares are owned by institutional investors. 2.2% of Tandem Diabetes Care shares are owned by insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is TNDM or KIDS more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to OrthoPediatrics' net margin of -15.00%. OrthoPediatrics' return on equity of -5.78% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-14.84% -44.19% -11.99% OrthoPediatrics -15.00%-5.78%-4.80% Do analysts rate TNDM or KIDS? Tandem Diabetes Care presently has a consensus target price of $53.81, suggesting a potential upside of 49.85%. OrthoPediatrics has a consensus target price of $39.00, suggesting a potential upside of 74.26%. Given OrthoPediatrics' higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Tandem Diabetes Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 3 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.83OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, TNDM or KIDS? Tandem Diabetes Care has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Does the MarketBeat Community favor TNDM or KIDS? Tandem Diabetes Care received 274 more outperform votes than OrthoPediatrics when rated by MarketBeat users. However, 64.18% of users gave OrthoPediatrics an outperform vote while only 61.28% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformTandem Diabetes CareOutperform Votes58461.28% Underperform Votes36938.72% OrthoPediatricsOutperform Votes31064.18% Underperform Votes17335.82% Which has better earnings and valuation, TNDM or KIDS? OrthoPediatrics has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$854.35M2.76-$222.61M-$1.93-18.61OrthoPediatrics$189.67M2.86-$20.97M-$1.23-18.20 Does the media prefer TNDM or KIDS? In the previous week, Tandem Diabetes Care and Tandem Diabetes Care both had 2 articles in the media. Tandem Diabetes Care's average media sentiment score of 1.59 beat OrthoPediatrics' score of 0.23 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryOrthoPediatrics beats Tandem Diabetes Care on 10 of the 17 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get OrthoPediatrics News Delivered to You Automatically Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KIDS vs. The Competition Export to ExcelMetricOrthoPediatricsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$541.95M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-18.1925.3790.0517.18Price / Sales2.8645.921,117.00116.99Price / CashN/A43.4442.9637.86Price / Book1.397.094.784.78Net Income-$20.97M$13.64M$120.31M$225.60M7 Day Performance1.18%-2.93%-1.92%-1.23%1 Month Performance-15.42%0.28%11.50%3.36%1 Year Performance-33.41%40.76%30.59%16.60% OrthoPediatrics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KIDSOrthoPediatrics3.8691 of 5 stars$22.38-0.9%$39.00+74.3%-29.8%$541.95M$189.67M-18.19200Analyst ForecastTNDMTandem Diabetes Care4.6384 of 5 stars$33.18+1.6%$53.81+62.2%+30.3%$2.18B$747.72M-16.922,400Positive NewsTMDXTransMedics Group4.0377 of 5 stars$64.29+0.0%$126.80+97.2%-20.1%$2.16B$241.62M68.36210Analyst ForecastSLNOSoleno Therapeutics4.477 of 5 stars$48.16+3.1%$74.83+55.4%+25.5%$2.08BN/A-14.0730RXSTRxSight2.9521 of 5 stars$38.86+4.2%$62.13+59.9%-11.8%$1.57B$89.08M-46.59220Analyst DowngradeINMDInMode3.6341 of 5 stars$18.14-0.7%$22.60+24.6%-21.7%$1.52B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8123 of 5 stars$9.45+3.2%$12.00+27.0%+1.7%$1.39B$342.80M16.65895ESTAEstablishment Labs2.5211 of 5 stars$46.33+0.7%$60.60+30.8%+73.3%$1.30B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2602 of 5 stars$27.32+2.3%$28.29+3.5%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoveragePLSEPulse Biosciences1.8256 of 5 stars$20.32+15.1%N/A+56.3%$1.25B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.03+0.3%$31.80+9.5%+59.5%$1.22B$384.90M-1,446.501,500 Related Companies and Tools Related Companies TNDM Competitors TMDX Competitors SLNO Competitors RXST Competitors INMD Competitors MDXG Competitors ESTA Competitors BLFS Competitors PLSE Competitors AORT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KIDS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
